European Health Economics
text size:

2011-07-01 : Rheumatology

Kobelt G, Lekander I, Lang A, Raffeiner B, Botsios C, Geborek P. Cost-effectiveness of etanercept treatment in early active rheumatoid arthritis followed by dose adjustment. International Journal of Technology Assessment in Health Care 2011;27(3):193-200

2009-12-03 : Neurology

Kobelt G, Kasteng F. The burden of Multiple Sclerosis and access to innovative treatments in Europe. A report. www.comparatorreports.se.

2009-10-12 : Rheumatology

Kobelt G, Kasteng F. The burden of Rheumatoid Arthritis and access to innovative treatments in Europe. A Report. www.comparatorreports.se

TopGo to top

© 2003 European Health Economics. All rights reserved. Created by MedSciNet AB.